Biography and Research Information
OverviewAI-generated summary
Sarah Heflin's research focuses on investigating novel therapeutic strategies for breast cancer, with a particular emphasis on targeting stem-like cells. Her work involves the synthesis and evaluation of modified salinomycin analogs. These compounds have demonstrated the ability to target these specific cancer cells in both two-dimensional and three-dimensional breast cancer models. Heflin has published one study in this area, contributing to the understanding of how drug modifications can enhance efficacy against resistant cancer populations. Her scholarly output, though limited in volume, is supported by collaborative efforts within the University of Arkansas for Medical Sciences, including shared publications with Robert L. Eoff, Melanie Clair Macnicol, Angus M. MacNicol, and Alicja Urbaniak.
Metrics
- h-index: 1
- Publications: 1
- Citations: 13
Selected Publications
-
Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models (2021)
Collaboration Network
Top Collaborators
Alicja Urbaniak
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Megan R. Reed
University of Arkansas for Medical Sciences
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Daniel Fil
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Anika Moorjani
University of Arkansas for Medical Sciences
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Michał Antoszczak
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Michał Sulik
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Adam Huczyński
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Michalina Kupsik
1 shared publication
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Robert L. Eoff
University of Arkansas for Medical Sciences
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Melanie C MacNicol
University of Arkansas for Medical Sciences
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Timothy C. Chambers
University of Arkansas for Medical Sciences
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Angus M. MacNicol
University of Arkansas for Medical Sciences
1 shared publication
In database
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Similar Researchers
Based on overlapping research topics
Timothy C. Chambers
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Breast Cancer Treatment Studies
Mesenchymal stem cell research
Darin Jones
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Drug Transport and Resistance Mechanisms
Computational Drug Discovery Methods
Drew Seale
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Breast Cancer Treatment Studies
Mesenchymal stem cell research
Peter A. Crooks
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Drug Transport and Resistance Mechanisms
Computational Drug Discovery Methods
Xiuqi Wang
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Drug Transport and Resistance Mechanisms
Computational Drug Discovery Methods
Steven A. Chambers
Arkansas State University
Cancer Treatment and Pharmacology
Drug Transport and Resistance Mechanisms
Computational Drug Discovery Methods